234 related articles for article (PubMed ID: 36907368)
1. Therapeutic deep eutectic solvents: A comprehensive review of their thermodynamics, microstructure and drug delivery applications.
Abdelquader MM; Li S; Andrews GP; Jones DS
Eur J Pharm Biopharm; 2023 May; 186():85-104. PubMed ID: 36907368
[TBL] [Abstract][Full Text] [Related]
2. Eutectic solutions for healing: a comprehensive review on therapeutic deep eutectic solvents (TheDES).
Kalantri S; Vora A
Drug Dev Ind Pharm; 2024 May; 50(5):387-400. PubMed ID: 38634708
[TBL] [Abstract][Full Text] [Related]
3. Towards a greater understanding of the deep eutectic phenomenon through examination of the lidocaine-NSAID therapeutic deep eutectic systems.
Li S; Abdelquader MM; Andrews GP; Jones DS
Eur J Pharm Biopharm; 2024 Jul; 200():114329. PubMed ID: 38761870
[TBL] [Abstract][Full Text] [Related]
4. Pharmaceutical applications of therapeutic deep eutectic systems (THEDES) in maximising drug delivery.
Javed S; Mangla B; Sultan MH; Almoshari Y; Sivadasan D; Alqahtani SS; Madkhali OA; Ahsan W
Heliyon; 2024 May; 10(9):e29783. PubMed ID: 38694051
[TBL] [Abstract][Full Text] [Related]
5. A comparison between pure active pharmaceutical ingredients and therapeutic deep eutectic solvents: Solubility and permeability studies.
Duarte AR; Ferreira AS; Barreiros S; Cabrita E; Reis RL; Paiva A
Eur J Pharm Biopharm; 2017 May; 114():296-304. PubMed ID: 28189620
[TBL] [Abstract][Full Text] [Related]
6. Investigation on drug solubility enhancement using deep eutectic solvents and their derivatives.
Li Z; Lee PI
Int J Pharm; 2016 May; 505(1-2):283-8. PubMed ID: 27079143
[TBL] [Abstract][Full Text] [Related]
7. Development of Polycaprolactone-Based metronidazole matrices for intravaginal extended drug delivery using a mechanochemically prepared therapeutic deep eutectic system.
Li S; Culkin A; Jones DS; Andrews GP
Int J Pharm; 2021 Jan; 593():120071. PubMed ID: 33246048
[TBL] [Abstract][Full Text] [Related]
8. Deep eutectic systems: An overview of fundamental aspects, current understanding and drug delivery applications.
Chakraborty S; Chormale JH; Bansal AK
Int J Pharm; 2021 Dec; 610():121203. PubMed ID: 34673164
[TBL] [Abstract][Full Text] [Related]
9. Deep eutectic solvents comprising active pharmaceutical ingredients in the development of drug delivery systems.
Pedro SN; Freire MG; Freire CSR; Silvestre AJD
Expert Opin Drug Deliv; 2019 May; 16(5):497-506. PubMed ID: 30955386
[TBL] [Abstract][Full Text] [Related]
10. Recent Developments on Ionic Liquids and Deep Eutectic Solvents for Drug Delivery Applications.
Qader IB; Prasad K
Pharm Res; 2022 Oct; 39(10):2367-2377. PubMed ID: 35739370
[TBL] [Abstract][Full Text] [Related]
11. Solubility of dapsone in deep eutectic solvents: Experimental analysis, molecular insights and machine learning predictions.
Jeliński T; Przybyłek M; Różalski R; Cysewski P
Polim Med; 2024; 54(1):15-25. PubMed ID: 38197603
[TBL] [Abstract][Full Text] [Related]
12. Design of controlled release systems for THEDES-Therapeutic deep eutectic solvents, using supercritical fluid technology.
Aroso IM; Craveiro R; Rocha Â; Dionísio M; Barreiros S; Reis RL; Paiva A; Duarte AR
Int J Pharm; 2015 Aug; 492(1-2):73-9. PubMed ID: 26142248
[TBL] [Abstract][Full Text] [Related]
13. Experimental and Theoretical Insights into the Intermolecular Interactions in Saturated Systems of Dapsone in Conventional and Deep Eutectic Solvents.
Cysewski P; Jeliński T; Przybyłek M
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675562
[TBL] [Abstract][Full Text] [Related]
14. Unveil the Anticancer Potential of Limomene Based Therapeutic Deep Eutectic Solvents.
Pereira CV; Silva JM; Rodrigues L; Reis RL; Paiva A; Duarte ARC; Matias A
Sci Rep; 2019 Oct; 9(1):14926. PubMed ID: 31624310
[TBL] [Abstract][Full Text] [Related]
15. Polymer-embedded deep eutectic solvents (PEDES) as a novel bio-enabling formulation approach.
Panbachi S; Beranek J; Kuentz M
Eur J Pharm Sci; 2023 Jul; 186():106463. PubMed ID: 37169098
[TBL] [Abstract][Full Text] [Related]
16. Emerging frontiers of deep eutectic solvents in drug discovery and drug delivery systems.
Zainal-Abidin MH; Hayyan M; Ngoh GC; Wong WF; Looi CY
J Control Release; 2019 Dec; 316():168-195. PubMed ID: 31669211
[TBL] [Abstract][Full Text] [Related]
17. Sketching neoteric solvents for boosting drugs bioavailability.
Álvarez MS; Zhang Y
J Control Release; 2019 Oct; 311-312():225-232. PubMed ID: 31521743
[TBL] [Abstract][Full Text] [Related]
18. Ionic liquids and deep eutectic solvents in natural products research: mixtures of solids as extraction solvents.
Dai Y; van Spronsen J; Witkamp GJ; Verpoorte R; Choi YH
J Nat Prod; 2013 Nov; 76(11):2162-73. PubMed ID: 24188074
[TBL] [Abstract][Full Text] [Related]
19. Harnessing therapeutic deep eutectic solvents in self-emulsifying systems to improve CBD delivery.
Balenzano G; Racaniello GF; Spennacchio A; Lopalco A; Iacobazzi RM; Lopedota AA; Laquintana V; Denora N
Int J Pharm; 2024 Jun; 659():124267. PubMed ID: 38797251
[TBL] [Abstract][Full Text] [Related]
20. Current understanding and insights towards protein stabilization and activation in deep eutectic solvents as sustainable solvent media.
Yadav N; Venkatesu P
Phys Chem Chem Phys; 2022 Jun; 24(22):13474-13509. PubMed ID: 35640592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
